Edwards Lifesciences Overview
Edwards Lifesciences Target Price
See Edwards Lifesciences's analyst price targets ($100) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$89.07
Average Target Price
$103.86
16.6% upside
16.6% upside7 analysts in the last 4 months
High: $110 | Low: $95
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-28 | UBS | $110 | 23.5% upside |  |
| 2026-07-24 | Leerink PartnersMike Kratky | $101 | 13.4% upside | |
| 2026-07-24 | Piper Sandler | $101 | 13.4% upside | |
| 2026-07-16 | Truist FinancialRichard Newitter | $95 | 6.7% upside | |
| 2026-07-13 | RBC Capital | $110 | 23.5% upside | |
| 2026-07-06 | Evercore ISI | $100 | 12.3% upside | |
| 2026-06-30 | BTIGMarie Thibault | $110 | 23.5% upside | |
| 2026-04-27 | Barclays | $110 | 23.5% upside | |
| 2026-04-24 | Truist Financial | $90 | 1% upside | |
| 2026-04-24 | Canaccord GenuityWilliam Plovanic | $85 |  4.6% downside | |
| 2026-04-24 | BTIG | $100 | 12.3% upside | |
| 2026-04-24 | Evercore ISIVijay Kumar | $93 | 4.4% upside | |
| 2026-04-13 | Mizuho Securities | $95 | 6.7% upside | |
| 2026-02-11 | Goldman SachsDavid Roman | $95 | 6.7% upside | |
| 2026-02-11 | Piper Sandler | $100 | 12.3% upside | |
| 2026-02-11 | Truist FinancialRichard Newitter | $89 | 0.1% downside | |
| 2026-02-04 | UBSDanielle Antalffy | $94 | 5.5% upside | |
| 2026-01-20 | Stifel Nicolaus | $110 | 23.5% upside | |
| 2026-01-20 | Piper Sandler | $98 | 10% upside | |
| 2026-01-12 | Barclays | $104 | 16.8% upside | |
| 2026-01-12 | Robert W. Baird | $90 | 1% upside | |
| 2026-01-12 | UBSDanielle Antalffy | $95 | 6.7% upside | |
| 2026-01-09 | Goldman SachsDavid Roman | $108 | 21.3% upside | |
| 2026-01-07 | Stifel NicolausRick Wise | $105 | 17.9% upside | |
| 2026-01-05 | Evercore ISI | $94 | 5.5% upside | |
| 2025-12-18 | Wells Fargo | $100 | 12.3% upside | |
| 2025-12-17 | Canaccord GenuityWilliam Plovanic | $87 | 2.3% downside | |
| 2025-12-16 | Robert W. BairdDavid Rescott | $87 | 2.3% downside | |
| 2025-12-08 | Barclays | $103 | 15.6% upside | |
| 2025-12-05 | RBC CapitalShagun Singh | $100 | 12.3% upside | |
| 2025-12-05 | Robert W. BairdDavid Rescott | $88 | 1.2% downside | |
| 2025-12-05 | Truist FinancialRichard Newitter | $92 | 3.3% upside | |
| 2025-12-05 | UBS | $92 | 3.3% upside | |
| 2025-12-05 | Stifel NicolausRick Wise | $100 | 12.3% upside | |
| 2025-12-05 | Wells FargoLarry Biegelsen | $96 | 7.8% upside | |
| 2025-12-05 | Canaccord GenuityWilliam Plovanic | $89 | 0.1% downside | |
| 2025-12-04 | BTIGMarie Thibault | $103 | 15.6% upside | |
| 2025-11-03 | BernsteinLee Hambright | $90 | 1% upside | |
| 2025-11-03 | Raymond JamesJayson Bedford | $96 | 7.8% upside | |
| 2025-11-03 | Canaccord GenuityWilliam Plovanic | $84 | 5.7% downside | |
| 2025-11-03 | UBS | $90 | 1% upside | |
| 2025-10-31 | Robert W. BairdDavid Rescott | $83 | 6.8% downside | |
| 2025-10-31 | RBC Capital | $95 | 6.7% upside | |
| 2025-10-31 | Goldman Sachs | $104 | 16.8% upside | |
| 2025-10-31 | National Bank | $92 | 3.3% upside | |
| 2025-10-31 | Barclays | $99 | 11.1% upside | |
| 2025-10-29 | JefferiesMatthew Taylor | $98 | 10% upside | |
| 2025-10-28 | Truist Financial | $87 | 2.3% downside | |
| 2025-10-27 | Truist Financial | $82 | 7.9% downside | |
| 2025-10-07 | Evercore ISI | $88 | 1.2% downside | |